ISOXAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
Provided is a compound of Formula (I) or a pharmaceutically acceptable salt thereof, that is a modulator of 5-HT2A and can be used in treating diseases and disorders associated with 5-HT2A serotonin receptor expression and/or activity. Thus, also provided are methods of treating 5HT2A-related diseas...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
05.05.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided is a compound of Formula (I) or a pharmaceutically acceptable salt thereof, that is a modulator of 5-HT2A and can be used in treating diseases and disorders associated with 5-HT2A serotonin receptor expression and/or activity. Thus, also provided are methods of treating 5HT2A-related diseases and disorders.
L'invention concerne un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci, qui est un modulateur du 5-HT2A et peut être utilisé dans le traitement de maladies et de troubles associés à l'expression et/ou à l'activité du récepteur sérotoninergique 5-HT2A. Ainsi, l'invention concerne également des procédés de traitement de maladies et de troubles liés au 5-HT2A. |
---|---|
Bibliography: | Application Number: WO2021US56694 |